Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia

作者：The French Cooperative Group on CLL, S.A. Johnson, Alex G Smith, H. Löffler, Eva Osby, Gunnar Juliusson, Bertold Emmerich, Peter J. Wyld, Wolfgang Hiddemann · 发表于：The Lancet · 年份：1996 · DOI：10.1016/s0140-6736(96)91681-5 · 被引用次数：442 · 研究领域：Chronic Lymphocytic Leukemia Research、Phagocytosis and Immune Regulation、Immunodeficiency and Autoimmune Disorders